1-20 of 3927
Journal Articles
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Acknowledgement to Reviewers

Subject Area:
Further Areas , Oncology , Pharmacology
Journal: Chemotherapy
Chemotherapy 1.
https://doi.org/10.1159/000535003
Published Online: 29 November 2023
View article titled, Acknowledgement to Reviewers
Open the PDF for Acknowledgement to Reviewers in another window
Journal Articles

Treatment and prognosis of newly diagnosed advanced-stage extranodal natural killer / T cell lymphoma: a single-center real-world study across two decades

Subject Area:
Further Areas , Oncology , Pharmacology
Yu-Ce Wei, Fei Qi, Bo Chen, Chang-Gong Zhang, Hui Fang, Di Zhang, Shu-Nan Qi, Yue Chai, Ye-Xiong Li, Mei Dong
Journal: Chemotherapy
Chemotherapy 1.
https://doi.org/10.1159/000535128
Published Online: 20 November 2023
View article titled, Treatment and prognosis of newly diagnosed advanced-stage extranodal natural killer / T cell lymphoma: a single-center real-world study across two decades
Open the PDF for Treatment and prognosis of newly diagnosed advanced-stage extranodal natural killer / T cell lymphoma: a single-center real-world study across two decades in another window
Journal Articles

Daptomycin-induced eosinophilic pneumonia: a case report and systematic review.

Subject Area:
Further Areas , Oncology , Pharmacology
Andrea Di Lorenzo, Lorenzo Vittorio Rindi, Laura Campogiani, Alessandra Imeneo, Grazia Alessio, Pier Giorgio Pace, Alessandra Lodi, Benedetta Rossi, Angela Maria Antonia Crea, Pietro Vitale, Dimitra Kontogiannis, Vincenzo Malagnino, Massimo Andreoni, Marco Iannetta, Loredana Sarmati
Journal: Chemotherapy
Chemotherapy 1.
https://doi.org/10.1159/000535190
Published Online: 14 November 2023
View article titled, Daptomycin-induced eosinophilic pneumonia: a case report and systematic review.
Open the PDF for Daptomycin-induced eosinophilic pneumonia: a case report and systematic review. in another window
Journal Articles

Review Article title: Natural Compounds with Antimicrobial Activities in oral Candida infections during head and neck radiotherapy

Subject Area:
Further Areas , Oncology , Pharmacology
Elena Imperia, Graziana Bonincontro, Annamaria Altomare, Giovanna Simonetti, Giovanni Gherardi, Elisa Brasili, Camilla Badiali, Manuela Bove, Gabriella Pasqua, Laura De Gara, Michele Cicala, Michele Pier Luca Guarino
Journal: Chemotherapy
Chemotherapy 1.
https://doi.org/10.1159/000534562
Published Online: 14 November 2023
View article titled, Review Article title: Natural Compounds with Antimicrobial Activities in oral Candida infections during head and neck radiotherapy
Open the PDF for Review Article title: Natural Compounds with Antimicrobial Activities in oral Candida infections during head and neck radiotherapy in another window
Journal Articles

Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case Report

Subject Area:
Further Areas , Oncology , Pharmacology
Sabrina Zoli, Cinzia Pellegrini, Beatrice Casadei, Alessandro Broccoli, Lisa Argnani, Laura Nanni, Vittorio Stefoni, Pier Luigi Zinzani
Journal: Chemotherapy
Chemotherapy 1–4.
https://doi.org/10.1159/000534784
Published Online: 01 November 2023
View article titled, Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case Report
Open the PDF for Prolonged Complete Response with Lenalidomide in a Relapsed Diffuse Large B-Cell Lymphoma, Leg-Type: A Case Report in another window
Journal Articles

Simultaneous Tumor Shrinkage and Bronchial Perforation Induced by Nivolumab plus Cabozantinib Combination Therapy in a Patient with Collecting Duct Carcinoma

Subject Area:
Further Areas , Oncology , Pharmacology
Hiroki Okumura, Kyoko Murase, Suguru Oka, Rika Kizawa, Takeshi Yamaguchi, Yuko Tanabe, Koichi Suyama, Kazushige Sakaguchi, Shinji Urakami, Yuji Miura
Journal: Chemotherapy
Chemotherapy 1–4.
https://doi.org/10.1159/000534470
Published Online: 11 October 2023
View article titled, Simultaneous Tumor Shrinkage and Bronchial Perforation Induced by Nivolumab plus Cabozantinib Combination Therapy in a Patient with Collecting Duct Carcinoma
Open the PDF for Simultaneous Tumor Shrinkage and Bronchial Perforation Induced by Nivolumab plus Cabozantinib Combination Therapy in a Patient with Collecting Duct Carcinoma in another window
Journal Articles

FDG-PET in Relapsed/Refractory Hodgkin Lymphoma: a practical approach.: Hodgkin Lymphoma FDG/PET

Subject Area:
Further Areas , Oncology , Pharmacology
Valeria Tomarchio, Luigi Rigacci
Journal: Chemotherapy
Chemotherapy 1.
https://doi.org/10.1159/000533766
Published Online: 14 September 2023
View article titled, FDG-PET in Relapsed/Refractory Hodgkin Lymphoma: a practical approach.: Hodgkin Lymphoma FDG/PET
Open the PDF for FDG-PET in Relapsed/Refractory Hodgkin Lymphoma: a practical approach.: Hodgkin Lymphoma FDG/PET in another window
Journal Articles

Fighting Antimicrobial Resistance and Healthcare-Associated Infections in EU-JAMRAI: The One-Health Response from Italy

Subject Area:
Further Areas , Oncology , Pharmacology
Luca Busani, Roberta Creti, Elisa Fabbro, Francesca Prestinaci, Annalisa Pantosti, Anna Maria Marella, Silvio Brusaferro, Michela Sabbatucci
Journal: Chemotherapy
Chemotherapy 1–8.
https://doi.org/10.1159/000531684
Published Online: 06 September 2023
View article titled, Fighting Antimicrobial Resistance and Healthcare-Associated Infections in EU-JAMRAI: The One-Health Response from Italy
Open the PDF for Fighting Antimicrobial Resistance and Healthcare-Associated Infections in EU-JAMRAI: The One-Health Response from Italy in another window
Journal Articles

A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab

Subject Area:
Further Areas , Oncology , Pharmacology
Federica Plano, Salvatrice Mancuso, Giulia Maria Camarda, Maria Giulia Butera, Giuseppe Sucato, Giuseppe Alecci, Ada Maria Florena, Salvatore Perrone, Sergio Mario Siragusa
Journal: Chemotherapy
Chemotherapy 1–5.
https://doi.org/10.1159/000533235
Published Online: 25 August 2023
View article titled, A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab
Open the PDF for A Multicentric Castleman Disease Associated with Mixed Warm and Cold Antibody-Mediated AHA Responsive to Siltuximab in another window
Journal Articles

Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC 24 Target in Critically Ill Patients

Subject Area:
Further Areas , Oncology , Pharmacology
Zhi Rao, Si-ming Guo, Yan-ming Wei
Journal: Chemotherapy
Chemotherapy 1–7.
https://doi.org/10.1159/000531638
Published Online: 17 August 2023
View article titled, Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC 24 Target in Critically Ill Patients
Open the PDF for Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC 24 Target in Critically Ill Patients in another window
Journal Articles

Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case Report

Subject Area:
Further Areas , Oncology , Pharmacology
Marta Banchi, Tiziana Lanzolla, Arianna Di Napoli, Arianna Bandini, Guido Bocci, Maria Christina Cox
Journal: Chemotherapy
Chemotherapy 1–5.
https://doi.org/10.1159/000533236
Published Online: 07 August 2023
View article titled, Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case Report
Open the PDF for Complete Remission of a Diffuse Large B-Cell Lymphoma in a Young Patient, with Severe Tuberous Sclerosis, Treated with Metronomic Chemotherapy and Ibrutinib: A Case Report in another window
Journal Articles

Ceramide Analog 5cc Overcomes TRAIL Resistance by Enhancing JNK Activation and Repressing XIAP Expression in Metastatic Colon Cancer Cells

Subject Area:
Further Areas , Oncology , Pharmacology
Qiqian Huang, Feiyan Liu
Journal: Chemotherapy
Chemotherapy 1–9.
https://doi.org/10.1159/000531757
Published Online: 10 July 2023
View article titled, Ceramide Analog 5cc Overcomes TRAIL Resistance by Enhancing JNK Activation and Repressing XIAP Expression in Metastatic Colon Cancer Cells
Open the PDF for Ceramide Analog 5cc Overcomes TRAIL Resistance by Enhancing JNK Activation and Repressing XIAP Expression in Metastatic Colon Cancer Cells in another window
Journal Articles

Why metformin should not be used as an oxidative phosphorylation inhibitor in cancer patients

Subject Area:
Further Areas , Oncology , Pharmacology
Minas Sakellakis
Journal: Chemotherapy
Chemotherapy 1.
https://doi.org/10.1159/000531606
Published Online: 21 June 2023
View article titled, Why metformin should not be used as an oxidative phosphorylation inhibitor in cancer patients
Open the PDF for Why metformin should not be used as an oxidative phosphorylation inhibitor in cancer patients in another window
Journal Articles

Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis

Subject Area:
Further Areas , Oncology , Pharmacology
Liang Wang, Juyuan Li, Huamin Chen
Journal: Chemotherapy
Chemotherapy 1–12.
https://doi.org/10.1159/000531524
Published Online: 20 June 2023
View article titled, Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis
Open the PDF for Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis in another window
Journal Articles

Long-Term Progression-Free Survival of a Pre-Treated Patient with Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil

Subject Area:
Further Areas , Oncology , Pharmacology
Gerlinde Maria Michl, Florian M. Vogt, Andreas Nouriani, Roland Ladurner, Marcus Kremer, Timo Reisländer, Marlies Michl
Journal: Chemotherapy
Chemotherapy 1–8.
https://doi.org/10.1159/000531525
Published Online: 19 June 2023
View article titled, Long-Term Progression-Free Survival of a Pre-Treated Patient with Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil
Open the PDF for Long-Term Progression-Free Survival of a Pre-Treated Patient with Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil in another window
Journal Articles

Efficacy of PD-1 Inhibitors in First-Line Treatment for Advanced Gastroesophageal Junction and Gastric Cancer by Subgroups: A Systematic Review and Meta-Analysis

Subject Area:
Further Areas , Oncology , Pharmacology
Shengqi Fei, Yu Lu, Jing Chen, Jia Qi, Wenxuan Wu, Beidi Wang, Yaxuan Han, Kefan Wang, Xiaying Han, Haiyan Zhou, Jun Wang, Jian Chen
Journal: Chemotherapy
Chemotherapy 197–209.
https://doi.org/10.1159/000531457
Published Online: 16 June 2023
View article titled, Efficacy of PD-1 Inhibitors in First-Line Treatment for Advanced Gastroesophageal Junction and Gastric Cancer by Subgroups: A Systematic Review and Meta-Analysis
Open the PDF for Efficacy of PD-1 Inhibitors in First-Line Treatment for Advanced Gastroesophageal Junction and Gastric Cancer by Subgroups: A Systematic Review and Meta-Analysis in another window
Journal Articles

Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report

Subject Area:
Further Areas , Oncology , Pharmacology
Marianna Gentilini, Beatrice Casadei, Alice Morigi, Ginevra Lolli, Marco Ferrari, Matteo Carella, Lisa Argnani, Pier Luigi Zinzani
Journal: Chemotherapy
Chemotherapy 1–3.
https://doi.org/10.1159/000527059
Published Online: 13 June 2023
View article titled, Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report
Open the PDF for Endobronchial Presentation of Hodgkin Lymphoma Responding to Pembrolizumab: A Case Report in another window
Journal Articles

Initiating Treatment with Low Fluorouracil Dose and Titrating According to Blood Levels in Patients Treated with a 46-Hour Continuous Infusion

Subject Area:
Further Areas , Oncology , Pharmacology
Ahmad Waleed Khatib, Samuel Maxwell Selub, Anton Uryvaey, Jalal Baranseh, Ayelet Shai
Journal: Chemotherapy
Chemotherapy (2023) 68 (2): 95–101.
https://doi.org/10.1159/000526827
Published Online: 06 June 2023
View article titled, Initiating Treatment with Low Fluorouracil Dose and Titrating According to Blood Levels in Patients Treated with a 46-Hour Continuous Infusion
Open the PDF for Initiating Treatment with Low Fluorouracil Dose and Titrating According to Blood Levels in Patients Treated with a 46-Hour Continuous Infusion in another window
Journal Articles

Targeted Therapy of Non-Small Cell Lung Cancer and Liver Cancer: Functional Nanocarriers for the Delivery of Cisplatin and Tissue Factor Pathway Inhibitor-2

Subject Area:
Further Areas , Oncology , Pharmacology
MingZhong Ma, JianWei He, Bo Gao, JianXun Cao, DaMing Li, YongChun Li, Gang Huang, Xing Zhou
Journal: Chemotherapy
Chemotherapy (2023) 68 (2): 73–86.
https://doi.org/10.1159/000527536
Published Online: 06 June 2023
View article titled, Targeted Therapy of Non-Small Cell Lung Cancer and Liver Cancer: Functional Nanocarriers for the Delivery of Cisplatin and Tissue Factor Pathway Inhibitor-2
Open the PDF for Targeted Therapy of Non-Small Cell Lung Cancer and Liver Cancer: Functional Nanocarriers for the Delivery of Cisplatin and Tissue Factor Pathway Inhibitor-2 in another window
Journal Articles

Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience

Subject Area:
Further Areas , Oncology , Pharmacology
Taiki Okumura, Takuro Noguchi, Nodoka Sekiguchi, Takashi Kobayashi, Shintaro Kanda, Kouichi Ida, Tomonori Minagawa, Shigeo Tokumaru, Takeji Umemura, Tomonobu Koizumi
Journal: Chemotherapy
Chemotherapy (2023) 68 (2): 87–94.
https://doi.org/10.1159/000527377
Published Online: 06 June 2023
View article titled, Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience
Open the PDF for Clinical Analysis of Extrapulmonary Neuroendocrine Carcinoma: A Retrospective and Single Institution Experience in another window